Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05801588 · ClinicalTrials.gov registry record · NA
Participating in T'ai Chi to Reduce Back Pain and Improve Quality of Life
A NA study, sponsored by New York Medical College.
- Completed
- Registry status
- NA
- Development phase
- 350
- Enrollment target
NCT05801588: Completed NA study, sponsored by New York Medical College.
NCT05801588 is a NA study that has completed, run by New York Medical College. The registered enrollment target is 350 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05801588, a NA study, has completed, sponsored by New York Medical College.
- COMPLETED
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
Study Summary
The purpose of the study is to examine the implementation strategy, in terms of feasibility and the possible benefits, of a free online Zoom t'ai chi and qigong gentle movement and meditation program to reduce back pain and improve sleep and quality of life among those with chronic back pain. The primary objective of this study is to examine whether a safe and moderate online t'ai chi and qigong exercise program, offered without cost to individuals with chronic back pain, improves pain levels, sleep, and quality of life; The secondary objective is to explore whether improvements in pain levels are different among smokers and those with unhealthy BMI than among others.
Primary Outcome
The Oswestry Disability Index (ODI) is a commonly used outcome measure for individuals with low back pain. The ODI includes 10 questions about pain intensity, personal care, lifting, walking, sitting, standing, sleeping, sex life, social life and traveling, each based upon a 6-item Likert scale. Each section is scored on a 0-5 scale, 5 representing the greatest disability. If a respondent does not answer all 10 questions, then average scores and levels of disability are adjusted to account for s
Interventions
- OTHER Usual care
- OTHER T'ai Chi and Qigong Rehabilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2022-09-22 |
| Est. Completion | 2023-12-26 |
| Phase | NA |
What the finished NCT05801588 record still lists
NCT05801588 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual care is the first listed.
NCT05801588 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05801588 about?
NCT05801588 is a clinical study titled "Participating in T'ai Chi to Reduce Back Pain and Improve Quality of Life". The purpose of the study is to examine the implementation strategy, in terms of feasibility and the possible benefits, of a free online Zoom t'ai chi and qigong gentle movement and meditation program to reduce back pain and improve sleep and quality of life among those with chronic back pain. The pr...
What is the current status of trial NCT05801588?
This trial is currently completed. It is a NA study. The enrollment target is 350 participants. The study started on 2022-09-22. Estimated completion is 2023-12-26.
What interventions are being tested in trial NCT05801588?
The interventions under investigation include: Usual care (OTHER), T'ai Chi and Qigong Rehabilitation (OTHER).
Who is sponsoring clinical trial NCT05801588?
This trial is sponsored by New York Medical College, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05801588's enrollment target sits among peer trials
350 292nd of 2000 higher than 1,699 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI